| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | 0.057 | 0.2 |
| mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | RITA | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | etoposide | GDSC1000 | pan-cancer | AAC | 0.047 | 0.2 |